{
    "clinical_study": {
        "@rank": "26585", 
        "acronym": "Low Dose ISB", 
        "arm_group": [
            {
                "arm_group_label": "Low Dose (20 mL) Local Anesthetic", 
                "arm_group_type": "Experimental", 
                "description": "Intervention to be administered is a total volume of 20 mL local anesthetic containing a 1:1 mixture of 1.5% Mepivacaine: 0.5% Bupivacaine."
            }, 
            {
                "arm_group_label": "Control Dose (40 mL) Local Anesthetic", 
                "arm_group_type": "Active Comparator", 
                "description": "Intervention to be administered is a total volume of 40 mL local anesthetic containing a 1:1 mixture of 1.5% Mepivacaine: 0.5% Bupivacaine"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine if a decrease in the standard volume of local\n      anesthetic used to numb your shoulder area before shoulder arthroscopy will provide adequate\n      anesthesia for the procedure and decrease the amount of time until you are ready for\n      discharge from the hospital."
        }, 
        "brief_title": "Effect of Local Anesthetic Dose on Interscalene Block", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Shoulder Arthroscopy", 
            "Interscalene Block"
        ], 
        "detailed_description": {
            "textblock": "Traditionally, an interscalene block is done either with nerve stimulator or ultrasound\n      guided using 40-60mL of local anesthetic.  The study plans to investigate the difference in\n      hand grip strength post-operatively in patients who will receive interscalene blocks with\n      40mL versus a lower dose (20mL) of local anesthetic.  We suspect the lower dose will achieve\n      adequate surgical anesthesia while creating less motor block and thus, increase patient\n      satisfaction, present fewer complications or adverse affects and decrease time in the\n      recovery room."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age: 18 - 80 years old\n\n          -  Surgical time < 2.5 hours\n\n          -  ASA I, II or III\n\n          -  Shoulder arthroscopy\n\n        Exclusion Criteria:\n\n          -  Age < 18 or > 80 years old\n\n          -  Chronic pain patients (on narcotics/opioids > 3 months)\n\n          -  Open shoulder surgical procedure\n\n          -  BMI > 40\n\n          -  Pre-existing neurological condition\n\n          -  Patient refusal of interscalene block\n\n          -  Severe respiratory disease or hemidiaphragmatic dysfunction\n\n          -  Allergy to any local anesthetics\n\n          -  Planned general anesthesia"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "154", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 24, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01701115", 
            "org_study_id": "2012-011"
        }, 
        "intervention": [
            {
                "arm_group_label": "Low Dose (20 mL) Local Anesthetic", 
                "description": "Anesthetic volume:\nInvestigational group: A 1:1 Mepivacaine 1.5%: Bupivacaine 0.5% mixture for a total of 20 mL", 
                "intervention_name": "Low Dose (20 ml) Local Anesthetic Volume for Interscalene Block", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Control Dose (40 mL) Local Anesthetic", 
                "description": "Anesthetic volume:\nControl group: A 1:1 Mepivacaine 1.5%: Bupivacaine 0.5% mixture for a total of 40 mL", 
                "intervention_name": "Control Dose (40 mL) Local Anesthetic Volume for Interscalene Block", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Low Dose (20 mL) Local Anesthetic", 
                "intervention_name": "Low Dose (20 mL) Local Anesthetic (Mepivacaine:Bupivacaine)", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Mepivacaine", 
                    "Bupivacaine"
                ]
            }, 
            {
                "arm_group_label": "Control Dose (40 mL) Local Anesthetic", 
                "intervention_name": "Control Dose (40 mL) Local Anesthetic (Mepivacaine:Bupivacaine)", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Mepivacaine", 
                    "Bupivacaine"
                ]
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anesthetics, Local", 
                "Bupivacaine", 
                "Mepivacaine", 
                "Anesthetics"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Interscalene Block", 
        "lastchanged_date": "January 29, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10021"
                }, 
                "name": "Hospital for Special Surgery"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of Local Anesthetic Dose on Interscalene Block for Shoulder Arthroscopy, Patient Satisfaction and Return of Handgrip Strength", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The primary outcome will be handgrip strength as measured by a dynamometer.  A reading will be obtained at baseline (before the interscalene block), upon arrival to the PACU, every 60 minutes after entering the PACU and one reading immediately prior to patient discharge.  Two measurements will be taken bilaterally at each time point.", 
            "measure": "Handgrip Strength", 
            "safety_issue": "No", 
            "time_frame": "A one time assessment pre-operatively in the holding area and each hour (every hour up until 180 minutes) post-operatively in the PACU until patient discharge"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01701115"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Patient readiness to discharge- Evaluated every 15 minutes using the PADDS discharge criteria.\nBP and pulse within 20% of preoperative baseline\nSteady gait, no dizziness, or meets preoperative level\nMinimal nausea and vomiting: successfully treated with PO medication\nThe patient should have minimal or no pain\nPostoperative bleeding should be consistent with expected blood loss for the procedure", 
                "measure": "Patient Readiness to Discharge", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed every 15 minutes from entry into the PACU until discharge from the hospital up to 180 minutes post PACU arrival."
            }, 
            {
                "description": "Evaluated by the level of sedation necessary and the surgeon rating of the block. The block will be considered a success if the sedation did not exceed fentanyl 100mcg or propofol 80mcg/kg/min, and the surgeon rated the block as successful with no patient movement or acceptable with minimal patient movement. Conversion to general anesthesia will also be considered a block failure.", 
                "measure": "Success of the Block", 
                "safety_issue": "No", 
                "time_frame": "10 minutes post block induction in the Operating Room"
            }, 
            {
                "description": "Patient satisfaction will be evaluated using an online survey. If the patient does not complete the survey in 2 days following discharge, the patient will receive a phone call and the survey will be completed over the phone. While the survey is not a validated measurement of patient satisfaction, it has successfully been used at our institution for other research projects (IRB # 11100).", 
                "measure": "Patient Satisfaction", 
                "safety_issue": "No", 
                "time_frame": "POD 2 - 3 (48-72 hours after the surgical procedure)"
            }, 
            {
                "description": "Side effects will also be evaluated by the blinded research assistant\nHoarseness- The patient will subjectively state whether they sound hoarse\nHorners- Will be evaluated post-operatively in the PACU", 
                "measure": "Side Effects", 
                "safety_issue": "No", 
                "time_frame": "Duration of stay in the PACU"
            }
        ], 
        "source": "Hospital for Special Surgery, New York", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hospital for Special Surgery, New York", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}